Checkpoint Therapeutics, Inc.
Checkpoint Therapeutics, Inc. (CKPT) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 120 transactions totaling $1.9M, demonstrating a bearish sentiment with -$1.2M in net insider flow. The most recent transaction on Jun 26, 2024 involved a sale of 13,038 shares valued at $26.9K.
CKPT Insider Activity Summary
Who Is Buying CKPT Stock?
No significant insider buying has been recorded for CKPT in the recent period.
Who Is Selling CKPT Stock?
No significant insider selling has been recorded for CKPT in the recent period.
Is Checkpoint Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CKPT is bearish with an Insider Alignment Score of 19/100 and a net flow of -$1.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CKPT Frequently Asked Questions
Understanding CKPT Insider Activity
Insider trading at Checkpoint Therapeutics, Inc. (CKPT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading CKPT stock, having executed 120 transactions in the past 90 days. The most active insider is James F. Oliviero III (Executive), who has made 36 transactions totaling $2.8M.
Related Tools
Track Checkpoint Therapeutics, Inc. Insider Activity
Get notified when executives and directors at CKPT file new Form 4 transactions